COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy
James Coulson, A. Adams, L A Gray, Andrew Evans
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Ritonavir2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineBetacoronavirusVirologyCoronavirus InfectionsAntiretroviral therapyViral loadInternal medicineHuman immunodeficiency virus (HIV)Infectious disease (medical specialty)DiseaseOutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesDrug-Induced Adverse Reactions